The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma
2022 · Clinical Cancer Research · 47 citations
https://doi.org/10.1158/1078-0432.ccr-21-1643
G
Gaia Giannone
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
103
Papers
1.3K
Citations
18
h-index
25
i10-index
Gaia Giannone is an academic researcher. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Cancer Genomics and Diagnostics & PARP inhibition in cancer therapy. The author has an h-index of 18, co-authored 88 publications.
ORCID: 0000-0003-1991-039XPapers by this author
worksValidation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers
2020 · Journal of Ovarian Research · 10 citations
https://doi.org/10.1186/s13048-020-00655-2
A new player in the treatment of HER2-positive tumours
2019 · The Lancet Oncology · 4 citations
https://doi.org/10.1016/s1470-2045(19)30168-8
High Grade Serous Ovarian Cancers With Brain Metastasis Are Strongly Enriched In BRCA1 And BRCA2 Mutations
2025 · International Journal of Gynecological Cancer · 0 citations
https://doi.org/10.1016/j.ijgc.2024.101479
Systematic curation and analysis of ovarian cancer data across multiple electronic record systems held within the UK National Health Service: a tertiary referral centre experience
2025 · ESMO Real World Data and Digital Oncology · 0 citations
https://doi.org/10.1016/j.esmorw.2025.100150
3153P Health-related quality of life assessment and results in clinical trials testing new cancer drugs approved by the European Medicines Agency (EMA) between 2019 and 2024
2025 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2025.08.1625
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat